Coloplast AS (XTER:CBHD) COGS-to-Revenue : 0.32 (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Coloplast AS COGS-to-Revenue?

Coloplast AS's Cost of Goods Sold for the three months ended in Jun. 2024 was €300 Mil. Its Revenue for the three months ended in Jun. 2024 was €922 Mil.

Coloplast AS's COGS to Revenue for the three months ended in Jun. 2024 was 0.32.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Coloplast AS's Gross Margin % for the three months ended in Jun. 2024 was 67.51%.

Coloplast AS COGS-to-Revenue Historical Data

The historical data trend for Coloplast AS's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS COGS-to-Revenue Chart

Coloplast AS Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

COGS-to-Revenue

Get a 7-Day Free Trial

0.32

0.31

0.33

Coloplast AS Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
COGS-to-Revenue	Get a 7-Day Free Trial															0.34	0.34	0.32	0.32	0.32

Coloplast AS COGS-to-Revenue Calculation

Coloplast AS's COGS to Revenue for the fiscal year that ended in Sep. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1095.806	/	3285.273
	=	0.33

Coloplast AS's COGS to Revenue for the quarter that ended in Jun. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	299.725	/	922.488
	=	0.32

Coloplast AS (XTER:CBHD) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Coloplast AS's Gross Margin % for the three months ended in Jun. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	299.725 / 922.488
	=	67.51 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Coloplast AS COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Coloplast AS's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Coloplast AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (XTER:CBHD) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

CLPBY:USA CLPBF:USA COLOBc:UK 0QBO:UK COLO B:Denmark CBHD:Germany

Address

Holtedam 1-3, Humlebaek, DNK, DK-3050

Website

https://www.coloplast.com

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines